Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Jornal de Pediatria

• Publication date

  1995-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-3476(95)70084-6PMID 7658282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Color Doppler flow mapping of the patent ductus arteriosus in very low birthweight neonates: Echocardiographic and clinical findings

  1994cited by this paper
• Regulation of Fetal Lamb Ductus Arteriosus Smooth Muscle Cell Migration by Indomethacin and Dexamethasone

  1993cited by this paper
• Persistent responsiveness of the neonatal ductus arteriosus in immature lambs: a possible cause for reopening of patent ductus arteriosus after indomethacin-induced closure.

  1985cited by this paper
• Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin.

  1984cited by this paper
• Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

  1983cited by this paper
• Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial.

  1983cited by this paper
• Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2.

  1983cited by this paper
• EARLY CLOSURE OF PATENT DUCTUS ARTERIOSUS WITH INDOMETHACIN IN PRETERM INFANTS WITH IDIOPATHIC RESPIRATORY DISTRESS SYNDROME

  1983cited by this paper
• Factors determining the loss of ductus arteriosus responsiveness to prostaglandin E.

  1983cited by this paper
• Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.

  1982cited by this paper
• Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus.

  1982cited by this paper
• Glucocorticoids alter the sensitivity of the lamb ductus arteriosus to prostaglandin E2.

  1981cited by this paper
• Effects of antenatal glucocorticoid administration on ductus arteriosus of preterm lambs.

  1981cited by this paper
• Prenatal administration of betamethasone for prevention of patient ductus arteriosus.

  1981cited by this paper
• Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial.

  1981cited by this paper
• Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus.

  1981cited by this paper
• Specificity and accuracy of echocardiographic and clinical criteria for diagnosis of patent ductus arteriosus in fluid-restricted infants.

  1981cited by this paper
• Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants.

  1980cited by this paper
• Timing of indomethacin therapy in persistent ductus.

  1980cited by this paper
• Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus.

  1979cited by this paper
• Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams.

  1979cited by this paper
• Fluid administration in the association of patent ductus arteriosus complicating respiratory distress syndrome.

  1977cited by this paper

• Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression

  2022cites this paper
• Association between endotypes of prematurity and pharmacological closure of patent ductus arteriosus: A systematic review and meta-analysis

  2022cites this paper
• Comparison of Intravenous Paracetamol versus Intravenous Ibuprofen in the Closure of Patent Ductus Arteriosus (PDA) in Preterm Infants

  2020cites this paper
• Efficacy and complications of oral ibuprofen and intravenous acetaminophen in closure of patent ductus arteriosus of preterm neonates

  2019cites this paper
• Tratamiento farmacológico del conducto arterioso permeable en recién nacidos prematuros

  2019cites this paper
• Factors associated with non-response to second course indomethacin for PDA treatment in preterm neonates

  2018cites this paper
• Reopening of the ductus arteriosus in preterm infants; Clinical aspects and subsequent consequences

  2018influential citation
• Hemodynamic assessment of the patent ductus arteriosus: Beyond ultrasound.

  2018cites this paper
• Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants

  2018cites this paper
• Predictors of PDA Treatment in Preterm Neonates Who Had Received Prophylactic Indomethacin

  2017cites this paper
• 22 – Injury to the Developing Preterm Brain: Intraventricular Hemorrhage and White Matter Injury

  2017cites this paper
• Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports

  2017cites this paper
• Estudio descriptivo del manejo del ductus arterioso persistente en una unidad de neonatología de tercer nivel y su adecuación a la evidencia actual

  2016influential citation
• THE EFFECT OF ORAL IBUPROFEN AND ORAL ACETAMINOPHEN IN THE PATENT DUCTUS ARTERIOSUS (PDA) IN PRETERM INFANTS BORN IN KOUVSAR HOSPITAL OF QAZVIN (A COMPARATIVE STUDY)

  2016cites this paper
• Intravenous paracetamol for PDA closure in the preterm: a single-center experience

  2016cites this paper
• Predictors of successful closure of patent ductus arteriosus with indomethacin

  2015cites this paper
• Diagnosis and management of persistent pulmonary hypertension of the newborn.

  2015cites this paper
• The cardiovascular system

  2015cites this paper
• High-Dose Oral Ibuprofen in Treatment of Patent Ductus Arteriosus in Full-Term Neonates

  2015cites this paper
• Analyse de l'évolution des prématurés après opération du canal artériel : cohorte récente : 2010-2014

  2015cites this paper
• Mini-symposium : Alveolar and Vascular Transition at Birth Diagnosis and management of persistent pulmonary hypertension of the newborn

  2015cites this paper
• ANALYSE DE L'EVOLUTION DES PREMATURES APRES OPERATION DU CANAL ARTERIEL : COHORTE RECENTE

  2015cites this paper
• Comparison of Oral Ibuprofen with Oral Indomethacin for PDA Closure in Indian Preterm Neonates: A Randomized Controlled Trial

  2014cites this paper
• Randomised controlled clinical trial of standard versus echocardiographically guided ibuprofen treatment for patent ductus arteriosus in preterm infants: a pilot study

  2014cites this paper
• Risk Factors of Failure of Ibuprofen Treatment in Preterm Infants with Hemodynamically Significant Patent Ductus Arteriosus

  2014cites this paper
• Non-steroidal anti-inflammatory drugs (NSAIDs) in the management of patent ductus arteriosus (PDA) in preterm infants and variations in attitude in clinical practice: a flight around the world.

  2014cites this paper
• Surgical Ligation on Significant Patent Ductus Arteriosus in Very Low Birth Weight Infants: Comparison between Early and Late Ligations

  2014cites this paper
• Persistent pulmonary hypertension of the newborn: recent advances in pathophysiology and treatment.

  2013cites this paper
• Oral Ibuprofen versus Intravenous Indomethacin for the Treatment of Patent Ductus Arteriosus in Very Low Birth Weight Infants

  2013cites this paper
• Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

  2013cites this paper
• Patent Ductus Arteriosus in Premature Neonates

  2012cites this paper
• Patent ductus arteriosus in infants <29 weeks gestation — outcomes and factors affecting closure

  2012cites this paper
• Canal Arterial Patente Tratamento Percutâneo

  2012cites this paper
• Systematic review and network meta-analysis of intravenous ibuprofen vs. intravenous indomethacin vs. placebo in the management of clinically and/or echocardiographically important patent ductus arteriosus in preterm infants at greater than 24 hours of life

  2012cites this paper
• Improved Closure of Patent Ductus Arteriosus With High Doses of Ibuprofen

  2012cites this paper
• Chapter 13 – The Very Low Birth Weight Neonate with Hemodynamically Significant Ductus Arteriosus During the First Postnatal Week

  2012cites this paper
• Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus

  2012cites this paper
• Ibubrofen in the treatment of patent ductus arteriosus in preterm infants: what we know, what we still do not know.

  2012cites this paper
• Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.

  2012cites this paper
• Quantification of left-to-right shunt through Patent Ductus Arteriosus by colour Doppler

  2011cites this paper
• Quantification of left-to-right shunt through Patent Ductus Arteriosus by colour Doppler Harling, Solweig

  2011cites this paper
• Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment.

  2011cites this paper
• Clinical aspects of very‐low‐birthweight infants showing reopening of ductus arteriosus

  2011cites this paper
• Patent Ductus Arteriosus of the Preterm Infant

  2010cites this paper
• Management of patent ductus arteriosus in term or near-term neonates with respiratory distress.

  2010cites this paper
• Echocardiography predicts closure of patent ductus arteriosus in response to ibuprofen in infants less than 28 week gestational age.

  2010cites this paper
• Indomethacin Pharmacodynamics Are Altered by Surfactant: A Possible Challenge to Current Indomethacin Dosing Guidelines Created Before Surfactant Availability

  2010cites this paper
• Clinical and echocardiographic diagnosis of patent ductus arteriosus in premature neonates.

  2009cites this paper
• A Second Course of Ibuprofen Is Effective in the Closure of a Clinically Significant PDA in ELBW Infants

  2009cites this paper
• Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?

  2009cites this paper
• Optimum Use of Therapeutic Drug Monitoring and Pharmacokinetics-Pharmacodynamics in the NICU.

  2009cites this paper
• [Patent ductus arteriosus].

  2008cites this paper
• Ibuprofen Versus Continuous Indomethacin in Premature Neonates With Patent Ductus Arteriosus: Is the Difference in the Mode of Administration?

  2008cites this paper
• Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

  2008cites this paper
• [Final outcome of preterm neonates with and without surgical treatment of patent ductus arteriosus].

  2008cites this paper
• Intensive cardiac management in patients with trisomy 13 or trisomy 18

  2008cites this paper
• Acute Hemodynamic Decompensation Following Patent Ductus Arteriosus Ligation in Premature Infants

  2008cites this paper
• Predictors of Ductal Closure and Intestinal Complications in Very Low Birth Weight Infants Treated with Indomethacin

  2008cites this paper
• Evolución final de recién nacidos prematuros operados y no operados por persistencia del conducto arterioso

  2008cites this paper
• SIBEN's First Clinical Consensus: Diagnostic and Therapeutic Approach to the Patent Ductus Arteriosus in Preterm Infants

  2008cites this paper
• Ductus arterioso permeable

  2008cites this paper
• Primer consenso clínico de SIBEN: enfoque diagnóstico y terapéutico del ductus arterioso permeable en recién nacidos pretérmino

  2008cites this paper
• The pharmacological treatment of patent ductus arteriosus in premature infants with respiratory distress syndrome: oral ibuprofen vs. indomethacin

  2008cites this paper
• Delayed closure effect in preterm infants with patent ductus arteriosus

  2008cites this paper
• Chapter 9 – The Very Low Birth Weight Neonate with a Hemodynamically Significant Ductus Arteriosus during the First Postnatal Week

  2008cites this paper
• Orogastric and Intravenous Indomethacin Administration to Very Premature Neonates With Patent Ductus Arteriosus: Population Pharmacokinetics, Absolute Bioavailability, and Treatment Outcome

  2007cites this paper
• Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity

  2007cites this paper
• Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?

  2007cites this paper
• The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants

  2007cites this paper
• CYCLOOXYGENASE-2-DEPENDENT REMODELING OF THE DUCTUS ARTERIOSUS

  2007cites this paper
• Effect of prophylactic indomethacin in extremely low birth weight infants

  2006cites this paper
• Chapter 54 – Echocardiography in the Neonatal Intensive Care Unit

  2005cites this paper
• Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?

  2004cites this paper
• High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus

  2004cites this paper
• Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.

  2004cites this paper
• Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment.

  2003cites this paper
• Less invasive surgical closure of patent ductus arteriosus in extremely low birth weight infants.

  2003cites this paper
• Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.

  2003cites this paper
• Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.

  2003cites this paper
• Transfusion Volume in Infants With Very Low Birth Weight: A Randomized Trial of 10 Versus 20 mL/kg

  2002cites this paper
• Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.

  2002cites this paper
• Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus

  2002cites this paper
• Minimal Effective Dose of Indomethacin for the Treatment of Patent Ductus arteriosus in Preterm Infants

  2002cites this paper
• Current treatment strategies of symptomatic patent ductus arteriosus.

  2002cites this paper
• The persistently patent arterial duct in the premature infant

  2001cites this paper
• Surgical closure of patent ductus arteriosus in very-low-birth-weight infants

  2001cites this paper
• Maternal Vitamin A Administration and the Fetal Ductus Arteriosus: Commentary on the article by Wu et al. on page 747

  2001cites this paper
• Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment

  2001cites this paper
• Tissue hypoxia inhibits prostaglandin and nitric oxide production and prevents ductus arteriosus reopening.

  2000cites this paper
• Effects of perinatal indomethacin treatment on preterm infants

  2000cites this paper
• Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants

  2000cites this paper
• Prophylactic indomethacin: factors determining permanent ductus arteriosus closure.

  2000cites this paper
• , Sylvain Chemtob , Nahid Waleh , Cameron J . Koch production and prevents ductus arteriosus reopening Tissue hypoxia inhibits prostaglandin and nitric oxide

  2000cites this paper
• Primary bronchomalacia and patent ductus arteriosus: simultaneous surgical correction in an infant.

  1999cites this paper
• Smooth muscle cell proliferation in the ductus arteriosus and the descending aorta, and effects of enalapril on SMC proliferation in perinatal rats.

  1999cites this paper
• Permanent Anatomic Closure of the Ductus Arteriosus in Newborn Baboons: The Roles of Postnatal Constriction, Hypoxia, and Gestation

  1999cites this paper
• Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants.

  1999cites this paper
• Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus Severity

  1998cites this paper
• The pharmacology of the ductus arteriosus.

  1998cites this paper
• Low dose indomethacin via fetal vein or cerebral ventricle stimulates breathing movements in fetal sheep.

  1997cites this paper